Interestingly, the co-occurrence of NASH significantly upregulated the gene expression of Il23a, Il1b, Il36g, and Mip2, compared with that in IMQ-treated mice without NASH (Figure 4). Here, IL23A is linked to metabolic dysfunction-associated steatohepatitis.